MedPath

DIAMIND: Diabetes SMS text reminders for women who have had gestational diabetes mellitus to test for type 2 diabetes or impaired glucose tolerance in the postpartum period

Not Applicable
Active, not recruiting
Conditions
Gestational diabetes
Reproductive Health and Childbirth - Childbirth and postnatal care
Metabolic and Endocrine - Diabetes
Public Health - Health promotion/education
Registration Number
ACTRN12612000621819
Lead Sponsor
Women's and Children's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
Female
Target Recruitment
252
Inclusion Criteria

(a) Diagnosed with GDM in this pregnancy
(b) Access to a mobile phone
(c) Postnatal blood glucose level returned to normal before discharge
(d) Singleton or twin pregnancy

Exclusion Criteria

(a) Known (pre-existing) type 1 or type 2 diabetes mellitus
(b) Interpreter required
(c) Stillbirth

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Whether oral glucose tolerance testing has been undertaken by six months postpartum.<br><br>Details: <br>To determine whether or not oral glucose tolerance testing has been undertaken by 6 months postpartum, three main methods of data collection will be utilised: <br><br>(1) asking participants to let us know whether they have had an OGTT in the initial text message<br>(2) asking participants whether they have had an OGTT in the 6 month postpartum follow up questionnaire<br>(3) checking the clinical information system in the hospital to see whether an OGTT has been done<br><br>Further data collection methods may be considered if data collection is not adequately complete using these methods alone.[Six months postpartum]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath